New Delhi, Nov. 5: MedImmune is the newest member of the Human Vaccines Project, which will help to accelerate the research and development of vaccines and immunotherapies for infectious disease and cancer.
Incubated at the International AIDS Vaccine Initiative (IAVI), the Human Vaccines Project is an ambitious new public-private partnership seeking to transform the future of global disease prevention and treatment by solving the primary scientific obstacles impeding the research and development of new vaccines and immunotherapies.
MedImmune will help establish the Project’s global consortium, launch its research program and guide its scientific plan and future direction as a participant of the consortium and member of the Industrial Advisory Committee, a panel of leading industry partners that will advise the Project on its scientific plan and future direction.
Ronald Herbst, Vice President, Oncology Research and Development, MedImmune said that the human immune system is one of the most potent tools medicine has in the fight against disease and they look forward to sharing their biologics expertise in immunology and infectious disease, while working with some of the key leaders in this area to help advance drug and vaccine development against a wide range of diseases.
The Project’s mission is to accelerate the development of vaccines and immunotherapies against major global infectious diseases and cancers by decoding the human immune system. (ANI)